179 related articles for article (PubMed ID: 24993134)
1. Krüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells.
Shin SH; Kwon YW; Heo SC; Jeong GO; Kim BR; Seo EJ; Kim JH
Exp Mol Med; 2014 Jul; 46(7):e104. PubMed ID: 24993134
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells.
Hasegawa Y; Murph M; Yu S; Tigyi G; Mills GB
Mol Oncol; 2008 Jun; 2(1):54-69. PubMed ID: 19081821
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI.
Lee MJ; Heo SC; Shin SH; Kwon YW; Do EK; Suh DS; Yoon MS; Kim JH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1869-77. PubMed ID: 23735324
[TBL] [Abstract][Full Text] [Related]
4. Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.
Pan Y; Zhong LJ; Zhou H; Wang X; Chen K; Yang HP; Xiaokaiti Y; Maimaiti A; Jiang L; Li XJ
Acta Pharmacol Sin; 2012 Jun; 33(6):798-808. PubMed ID: 22669117
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth.
Do EK; Kim YM; Heo SC; Kwon YW; Shin SH; Suh DS; Kim KH; Yoon MS; Kim JH
Int J Biochem Cell Biol; 2012 Nov; 44(11):2069-76. PubMed ID: 22903068
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models.
Härmä V; Knuuttila M; Virtanen J; Mirtti T; Kohonen P; Kovanen P; Happonen A; Kaewphan S; Ahonen I; Kallioniemi O; Grafström R; Lötjönen J; Nees M
Oncogene; 2012 Apr; 31(16):2075-89. PubMed ID: 21996742
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
[TBL] [Abstract][Full Text] [Related]
9. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
10. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
11. In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.
Jenkins DE; Yu SF; Hornig YS; Purchio T; Contag PR
Clin Exp Metastasis; 2003; 20(8):745-56. PubMed ID: 14713108
[TBL] [Abstract][Full Text] [Related]
12. LPA Increases Tumor Growth and Bone Destruction Through Enhancement of Osteoclastogenic Cytokines.
Lindholm PF; Hwang YS
Anticancer Res; 2016 Jan; 36(1):61-70. PubMed ID: 26722028
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells.
Lin CC; Lin CE; Lin YC; Ju TK; Huang YL; Lee MS; Chen JH; Lee H
Biochem Biophys Res Commun; 2013 Nov; 440(4):564-9. PubMed ID: 24113377
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract][Full Text] [Related]
15. Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors.
Snyder LA; Damle R; Patel S; Bohrer J; Fiorella A; Driscoll J; Hawkins R; Stratton CF; Manning CD; Tatikola K; Tryputsen V; Packman K; Mamidi RNVS
Mol Cancer Ther; 2022 Jul; 21(7):1115-1124. PubMed ID: 35499386
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.
Lee SJ; No YR; Dang DT; Dang LH; Yang VW; Shim H; Yun CC
J Biol Chem; 2013 Aug; 288(35):25244-25253. PubMed ID: 23880760
[TBL] [Abstract][Full Text] [Related]
17. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
18. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
David M; Sahay D; Mege F; Descotes F; Leblanc R; Ribeiro J; Clézardin P; Peyruchaud O
PLoS One; 2014; 9(5):e97771. PubMed ID: 24828490
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells.
Lin CE; Chen SU; Lin CC; Chang CH; Lin YC; Tai YL; Shen TL; Lee H
PLoS One; 2012; 7(7):e41096. PubMed ID: 22911748
[TBL] [Abstract][Full Text] [Related]
20. Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model.
Heo SC; Lee KO; Shin SH; Kwon YW; Kim YM; Lee CH; Kim YD; Lee MK; Yoon MS; Kim JH
Biochim Biophys Acta; 2011 Dec; 1813(12):2061-70. PubMed ID: 21855581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
